Havva Serap Toru

ORCID: 0000-0002-4438-0434 · 5 papers in corpus
review 2024
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph17030311

Endometriosis and adenomyosis behave similarly to cancer. No current treatments represent a cure, even if there are several options, including hormonal and surgical therapy. In advanced or recurrent pathologies, however, personalized treatm…

review 2023
Diagnostics ·doi:10.3390/diagnostics13132265

This comprehensive review explores the genetic contributions to endometriosis and their potential impact on improving diagnostic techniques. The review begins by defining endometriosis and discussing its prevalence, emphasizing the need for…

2022
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics12123105

Dysgerminoma represents a rare malignant tumor composed of germ cells, originally from the embryonic gonads. Regarding its incidence, we do not have precise data due to its rarity. Dysgerminoma occurs at a fertile age. The preferred treatme…

2021
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-020-01932-1

ObjectiveTelomeres are repetitive sequences localized at the ends of eukaryotic chromosomes comprising noncoding DNA and telomere-binding proteins. TRF1 and TRF2 both bind to the double-stranded telomeric DNA to regulate its length througho…

article 2007
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.01.010

ObjectiveTo determine the effects of raloxifene and genistein on experimentally induced endometriosis in a rat model.DesignProspective, randomized animal study.SettingAnimal surgery laboratory in a university hospital.Animal(s)Thirty-three …